Topic Archives: Rare Disease

March 1, 2021 - Biotech, COVID-19, FDA, Healthcare, Pharma, Rare Disease, Regulatory

Rare Disease: Sustained Progress in Development Regardless of the Pandemic

By: Bethany J. Hills and Catherine M. Polizzi

Sunday, February 28, 2021, was Rare Disease Day. With so much focus on COVID-19 throughout 2020, it’s important to recognize the continued work done in rare disease drug development by sponsors and FDA throughout 2020. In addition, a number of policies implemented in response …›